Published in N Engl J Med on July 03, 1980
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol (1982) 2.20
Familial C1q deficiency associated with renal and cutaneous disease. Clin Exp Immunol (1981) 0.97
SLE like syndrome and functional deficiency of C1q in members of a large family. Clin Exp Immunol (1984) 0.96
Molecular cloning and characterization of the complementary DNA and gene coding for the B-chain of subcomponent C1q of the human complement system. Biochem J (1985) 0.95
A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE). Clin Exp Immunol (1982) 0.79
Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clin Exp Immunol (1993) 0.78
C1q nephropathy in two young sisters. Pediatr Nephrol (2007) 0.75
Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med (1970) 4.92
Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med (1970) 4.29
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera. Biochem J (1972) 4.06
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03
The proteolytic activation systems of complement. Annu Rev Biochem (1981) 3.85
The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med (1996) 3.79
Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet (1970) 3.78
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Cysteine desulfurase activity indicates a role for NIFS in metallocluster biosynthesis. Proc Natl Acad Sci U S A (1993) 3.59
Tuberculin response two years after BCG vaccination at birth. Arch Dis Child (1984) 3.48
Clinicopathological study of nephrotic syndrome in childhood. Lancet (1970) 3.13
Urine microscopy as an aid to detection of bacteriuria. Lancet (1975) 3.09
Cot deaths in Birmingham 1958-61. Med Sci Law (1965) 2.81
Structure-function relationships of the complement components. Immunol Today (1989) 2.74
Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann Intern Med (1993) 2.74
Serum-immunoglobulins in adult coeliac disease. Lancet (1969) 2.69
Schönlein-Henoch nephritis. Q J Med (1972) 2.64
Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region. Biochem J (1981) 2.63
Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement. Biochem J (1976) 2.62
Management of urinary tract infection. Arch Dis Child (1987) 2.57
Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol (1990) 2.55
A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement). Biochem J (1974) 2.53
Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) (1986) 2.47
Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J (1976) 2.46
Activation of the complement system by antibody-antigen complexes: the classical pathway. Adv Protein Chem (1979) 2.39
Management and dosing of warfarin therapy. Am J Med (2000) 2.36
Reactive haemolysis--a distinctive form of red cell lysis. Immunology (1968) 2.32
Prognosis of Henoch-Schönlein nephritis in children. Br Med J (1977) 2.32
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J (1966) 2.31
Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med (1990) 2.29
Mechanism for the desulfurization of L-cysteine catalyzed by the nifS gene product. Biochemistry (1994) 2.26
Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system. Biochem J (1985) 2.19
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med (1994) 2.15
Role of migratory birds in introduction and range expansion of Ixodes scapularis ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada. Appl Environ Microbiol (2008) 2.13
Ixodes scapularis ticks collected by passive surveillance in Canada: analysis of geographic distribution and infection with Lyme borreliosis agent Borrelia burgdorferi. J Med Entomol (2006) 2.12
C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis. Immunology (1972) 2.04
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Prevalence of symptomless urinary tract disease in Birmingham schoolchildren. I. Pyuria and bacteriuria. Br Med J (1969) 2.01
Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99
Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun (1997) 1.97
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Biochem J (1981) 1.95
C1q: structure, function, and receptors. Immunopharmacology (2000) 1.89
Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett (1989) 1.87
Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax (2000) 1.85
The biochemistry of complement. Nature (1978) 1.84
Secretory IgA in the serum. Lancet (1969) 1.84
Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med (1975) 1.81
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clin Exp Immunol (1981) 1.80
Is the risk of cancer increased in Asians living in the UK? Arch Dis Child (1994) 1.79
Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.78
The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement. Biochem J (1977) 1.78
Binomial cokriging for estimating and mapping the risk of childhood cancer. IMA J Math Appl Med Biol (1998) 1.77
Electrical threshold of the human heart. Br Heart J (1966) 1.75
Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody. Immunology (1971) 1.74
Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature (1988) 1.73
Carcinoid tumours of the appendix in children 1957-1986: incidence, treatment and outcome. Br J Surg (1993) 1.71
Contamination of protective clothing and nurses' uniforms in an isolation ward. J Hosp Infect (1983) 1.70
Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69
Occurrence of S-methyl thioesters in urines of humans after they have eaten asparagus. Science (1975) 1.69
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem (1997) 1.68
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med (1991) 1.68
Divided right ventricle: a review of its anatomical varieties. Pediatr Cardiol (1985) 1.65
Proteins involved in the activation and control of the two pathways of human complement. Biochem Soc Trans (1983) 1.64
Clinical significance of antenatal calyceal dilatation detected by ultrasound. Lancet (1990) 1.64
Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J (1976) 1.61
Symptomless haematuria in childhood. Br Med J (1970) 1.61
Gluten-sensitive diarrhea without evidence of celiac disease. Gastroenterology (1980) 1.59
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol (1999) 1.57
Secretory piece linked to IgM in individuals deficient in IgA. Nature (1970) 1.57
Stable isotope studies on the biosynthesis of lipoic acid in Escherichia coli. Biochemistry (1980) 1.56
The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost (2008) 1.55
Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet (1992) 1.53
Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children. Lancet (1972) 1.52
Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol (1973) 1.52
Long-term outcome for children with minimal-change nephrotic syndrome. Lancet (1985) 1.52
A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol (1977) 1.50
Renal biopsy diagnosis in children presenting with haematuria. Pediatr Nephrol (1998) 1.49
Coexistence of thin membrane and alport nephropathies in families with haematuria. Pediatr Nephrol (1999) 1.48
The detection of monosynaptic connexions from inspiratory bulbospinal neurones to inspiratory motoneurones in the cat. J Physiol (1985) 1.48
Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A (1988) 1.47
Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet (1992) 1.47
Identification of methyl coenzyme M as an intermediate in methanogenesis from acetate in Methanosarcina spp. J Bacteriol (1984) 1.47
Structure, organization, and regulation of the complement genes. Annu Rev Immunol (1988) 1.47
Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Arch Intern Med (1994) 1.46
Directional cloning of PCR products using exonuclease III. Nucleic Acids Res (1992) 1.46
Complete amino acid sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem J (1979) 1.45
Collectins--soluble proteins containing collagenous regions and lectin domains--and their roles in innate immunity. Protein Sci (1994) 1.45
Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect (1988) 1.44
Structural similarities between Thy-1 antigen from rat brain and immunoglobulin. Nature (1979) 1.42
Cytotoxic drug therapy in steroid-resistant glomerulonephritis. Proc R Soc Med (1967) 1.42
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. J Thromb Haemost (2011) 1.42
Steroid responsive nephrotic syndrome is more common in Asians. Arch Dis Child (1985) 1.41
Shoulder pain. West J Med (1982) 1.41
Renal scarring and vesicoureteric reflux. Arch Dis Child (1978) 1.41
Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J (1970) 1.41
Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q. Biochem J (1977) 1.40